Development and validation of measures to assess prevention and control of AMR in hospitals

Medical Care

Volumn 45, Issue 6, 2007, Pages 537-544

  Flanagan, Mindy ^a,b,h   Ramanujam, Rangaraj ^a,b,c,d   Sutherland, Jason ^a,b,e   Vaughn, Thomas ^f   Diekema, Daniel ^g   Doebbeling, Bradley N ^a,b,d,g  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b REGENSTRIEF INSTITUTE   (United States)

^c PURDUE UNIVERSITY   (United States)

^d Purdue University   (United States)

^e Division of Biostatistics

^f UNIVERSITY OF IOWA   (United States)

^g UNIVERSITY OF IOWA   (United States)

^h RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

AMR; Factor analysis; Measurement development; MRSA; Organizational

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL TRIAL; CROSS INFECTION; DRUG UTILIZATION; EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; FACTORIAL ANALYSIS; HEALTH CARE QUALITY; HEALTH SERVICES RESEARCH; HEALTH SURVEY; HUMAN; INFECTION CONTROL; METHODOLOGY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PENICILLIN RESISTANCE; PRACTICE GUIDELINE; REGRESSION ANALYSIS; REPRODUCIBILITY; STAPHYLOCOCCUS INFECTION; UNITED STATES;

ANTI-INFECTIVE AGENTS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; EVIDENCE-BASED MEDICINE; FACTOR ANALYSIS, STATISTICAL; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HEALTH SERVICES RESEARCH; HUMANS; INFECTION CONTROL; METHICILLIN RESISTANCE; MULTIVARIATE ANALYSIS; POPULATION SURVEILLANCE; PROGRAM EVALUATION; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; STAPHYLOCOCCAL INFECTIONS; UNITED STATES;

EID: 34249043849     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e31803bb48b     Document Type: Article

References (35)

1. Goldmann DA, Huskins WC. Control of nosocomial antimicrobialresistant bacteria: a strategic priority for hospitals worldwide. Clin Infect Dis. 1997;24(Suppl 1):S139-S145.
2. Jarvis WR. Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls: the complexity of the problem. Infect Control Hosp Epidemiol. 1996;17:490-495.
3. McGowan JE Jr, Tenover FC. Control of antimicrobial resistance in the health care system. Infect Dis Clin North Am. 1997;11:297-311.
4. Henderson DK. Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms. Am J Med. 2006;119(6 Suppl 1):S45-S52.
5. Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science. 1992;257:1050-1055.
6. Levy SB, O'Brien TF. Global antimicrobial resistance alerts and implications. Clin Infect Dis. 2005;41:S219-S220.
7. O'Brien TF. Emergence, spread, and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any microbial anywhere else. Clin Infect Dis. 2002; 34(Suppl 3):S78-S84.
8. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant micro organisms in hospitals. A challenge to hospital leadership. JAMA. 1996;275:234-240.
9. Anonymous. Recommendations for preventing the spread of vancomycin resistance. Hospital Infection Control Practices Advisory Committee (HICPAC). Infect Control Hosp Epidemiol. 1995;16:105-113.
10. Back NA, Linnemann CCJ, Pfaller MA, et al. Recurrent epidemics caused by a single strain of erythromycin-resistant Staphylococcus aureus. The importance of molecular epidemiology. JAMA. 1993;270:1329-1333.
11. Boyce JM. Treatment and control of colonization in the prevention of nosocomial infections. Infect Control Hosp Epidemiol. 1996;17:256-261.
12. Boyce JM. Vancomycin-resistant enterococcus. Detection, epidemiology, and control measures. Infect Dis Clin North Am. 1997;11:367-384.
13. Casewell MW. New threats to the control of methicillin-resistant Staphylococcus aureus. J Hosp Infect. 1995;30(Suppl):465-471.
14. Centers for Disease Control and Prevention. Outbreak of multidrug-resistant tuberculosis at a hospital - New York City, 1991. MMWR Morb Mortal Wkly Rep. 1993;42:427, 433-434.
15. Duncan RA. Controlling use of antimicrobial agents. Infect Control Hosp Epidemiol. 1997;18:260-266.
16. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis. 1993;16:750-755.
17. Alliance for the Prudent Use of Antibiotics. Antibiotic Resistance: Synthesis of Recommendations by Expert Policy Groups. Geneva: World Health Organization; 2001.
18. Siegel JD, Rhinehart E, Jackson M, et al. HICPAC. Management of Multidrug-Resistant Organisms in Healthcare Settings, 2006. Available at: www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf. Accessed November 21, 2006.
19. Ernst EJ, Diekema D, BootsMiller BB, et al. Are U.S. hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data? Diagn Microbiol Infect Dis. 2004;49: 141-145.
20. Dellinger EP, Gross PA, Barrett TL, et al. Quality standard for antimicrobial prophylaxis in surgical procedures. The Infectious Diseases Society of America. Infect Control Hosp Epidemiol. 1994; 15:182-188.
21. Fridkin SK, Manangan L, Bolyard E, et al. SHEA-CDC TB survey. Part I: status of TB infection control programs at member hospitals, 1989-1992. Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol. 1995;16:129-134.
22. Lawton RM, Fridkin SK, Gaynes RP, et al. Practices to improve antimicrobial use at 47 US hospitals: the status of the 1997 SHEA/IDSA position paper recommendations. Society for Healthcare Epidemiology of America/Infectious Diseases Society of America. Infect Control Hasp Epidemiol. 2000;21:256-259.
23. Diekema DJ, BootsMiller BB, Vaughn TE, et al. Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clin Infect Dis. 2004;38:78-85.
24. Deleted in proof.
25. Deleted in proof.
26. Ward MM, Diekema DJ, Yankey J, et al. Implementation of strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in U.S. hospitals. Infect Control Hosp Epidemiol. 2005; 26:21-30.
27. Flach SD, Diekema D, Yankey J, et al. Variation in the use of procedures to monitor antimicrobial resistance in U.S. hospitals. Infect Control Hosp Epidemiol. 2005;26:31-38.
28. Zillich AJ, Sutherland JM, Wilson SJ, et al. Antimicrobial use control measures to prevent and control antimicrobial resistance in US hospitals. Infect Control Hosp Epidemiol. 2006;27:1088-1095.
29. Field TS, Cadoret CA, Brown ML, et al. Surveying physicians: do components of the "Total Design Approach" to optimizing survey response rates apply to physicians? Med Care. 2002;40:596-605.
30. Little RJ, Rubin DB. Statistical Analysis With Missing Data. New York, NY: Wiley; 1987.
31. Bentler PM, Bonnet DG. Significance tests and goodness of fit in the analysis of covariance structures. Psychol Bull. 1980;88:588-606.
32. Bentler PM. EQS Structural Equations Program Manual. Los Angeles, CA: BMDP Statistical Software; 1989.
33. Loveday HP, Pellowe CM, Jones SR, et al. A systematic review of the evidence for interventions for the prevention and control of methicillin-resistant Staphylococcus aureus (1996-2004): report to the joint MRSA Working Party (Subgroup A). JHosp Infect. 2006;63(Suppl 1):S45-S70.
34. Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA. 2003;290:1899-1905.
35. Fridkin SK, Edwards JR, Tenover FC, et al. Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections. Clin Infect Dis. 2001;33:324-330.